查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829834

2025年全球病毒診斷檢測套組市場報告

Viral Diagnostic Test Kits Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，病毒診斷檢測套組市場呈現強勁成長勢頭，市場規模從2024年的162.6億美元增至2025年的174.8億美元，複合年成長率達7.5%。這段時期的成長歸因於醫療保健支出的增加、全球旅行的增加、慢性病毒感染疾病的增加、家用檢測套組需求的增加以及個人化醫療的發展。

預計未來幾年病毒診斷檢測套組市場規模將強勁成長，2029年將達到234億美元，複合年成長率為7.6%。預測期內的成長歸因於伊波拉病毒感染疾病的上升、出血熱發生率的上升、病毒感染疾病盛行率的上升、呼吸道融合細胞病毒盛行率的上升以及肝炎盛行率的上升。預測期內的主要趨勢包括技術進步、就地檢驗、人工智慧和數據分析、與數位健康記錄的整合以及次世代定序。

病毒診斷檢測套組是醫療實踐中用於檢測患者臨床樣本中病毒感染的設備。這些套件通常包含試劑、抗體或其他與特定病毒抗原或遺傳物質相互作用並產生可測量訊號的物質。它們可以檢測血液、唾液、鼻拭子和其他體液等樣本中的病毒顆粒、抗原和遺傳物質（例如 RNA 或 DNA）。

病毒診斷檢測套組主要分為傳統檢測和快速檢測。傳統病毒診斷檢測是基於實驗室的成熟方法，包括培養病毒、檢測病毒抗原和測量抗體反應。這些檢測包括直接螢光抗體 (DFA) 檢測、免疫層析檢測、基於逆轉錄聚合酶聚合酵素鏈鎖反應(rt-PCR) 的檢測、凝集試驗、固相檢測和流通式檢測。這些檢測的最終用戶包括實驗室、診所、醫院等。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供了病毒診斷檢測套組檢測套組的市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的病毒診斷檢測套組檢測套組檢測套組市場、市場趨勢和商業機會，為您提供在病毒診斷試劑盒行業取得成功所需的數據。這份病毒診斷檢測套組研究報告透過對產業現狀和未來狀況的詳細分析，為您提供了全面的觀點。

未來五年7.6%的預測成長率，較我們先前對該市場的預測略有下降0.5%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接影響美國，導致來自中國和韓國等關鍵地區的病毒抗原試劑和側流檢測組件的供應鏈中斷，從而導致疫情爆發時檢測試劑短缺和診斷成本增加。

病毒感染疾病的日益普及預計將在未來幾年推動病毒診斷檢測套組市場的成長。病毒感染疾病是由侵入宿主細胞並在其中複製的微觀病毒引起的，引起的症狀從輕微到嚴重不等，並影響身體的各個部位。感染疾病的增加是由於全球旅行、都市化、影響媒介傳播感染疾病的氣候變遷以及能夠引起疫情或傳播到新地區的新病毒株的出現等因素造成的。病毒診斷檢測套組透過檢測血液、唾液和鼻拭子等生物樣本中的病毒核酸（RNA 或 DNA）、抗原和抗體，在識別和確認特定病毒感染方面發揮關鍵作用。例如，根據美國疾病管制與預防中心 (CDC) 的數據，2022 年美國新增報告急性乙型肝炎病例 2,126 例，另有 16,729 例慢性B型肝炎病例。此外，美國14 個司法管轄區的急性乙型肝炎發病率高於全國平均水平，凸顯了對有效診斷工具的需求。因此，病毒感染疾病的日益普及是病毒診斷檢測檢測套組市場成長的主要驅動力。

為了保持競爭力，病毒診斷檢測檢測套組市場的主要企業正專注於開發病毒檢測試劑套件等創新產品。病毒檢測套件是一種診斷工具，旨在檢測生物樣本中的特定病毒，提供快速準確的結果並支持有效的疾病監測和管理。例如，2024 年 8 月，英國的 BlueStain Global Ltd. 推出了 MPox 病毒檢測套件。 BlueStain MPox 病毒檢測套件是一種快速診斷測試，可快速且準確地識別 MPox 病毒，只需 15 到 30 分鐘即可提供結果。該創新套件旨在透過及早發現和控制 MPox 疫情來改善公共衛生應對，特別是在資源有限的環境中。

2023年6月，英國生命科學公司Avacta Life Sciences以740萬英鎊（935萬美元）收購了Coris Bioconcept。 Avacta的這項策略措施旨在透過增強其快速診斷檢測產品組合來增強其在醫療診斷領域的能力，並擴大其市場影響力，尤其是在感染疾病控制和就地檢驗領域。 Coris Bioconcept總部位於比利時，專門從事快速診斷檢測套組的開發和製造，主要專注於用於檢測病毒和細菌病原體的橫向流動檢測。

病毒診斷檢測套組市場包括病毒培養試劑套件、分子診斷試劑套件、抗體檢測試劑套件、抗原檢測套件和多重PCR套件的銷售。該市場的價值為“出廠價”，即商品製造商或創造者出售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接出售給最終客戶的商品價值。該市場中的商品價值還包括商品創造者出售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球病毒診斷檢測套組：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球病毒診斷檢測套組市場：成長率分析
  • 全球病毒診斷檢測套組市場表現：規模與成長，2019-2024
  • 全球病毒診斷檢測套組市場預測：規模與成長，2024-2029年，2034年
  • 全球病毒診斷檢測套組：總目標市場（TAM）

第6章 市場細分

  • 全球病毒診斷檢測套組市場：檢驗、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 傳統測試
  • 快速檢測
  • 全球病毒診斷檢測套組市場（依檢測類型、效能及預測），2019-2024 年、2024-2029 年、2034 年
  • 直接螢光抗體（DFA）檢測
  • 層析法法
  • 基於逆轉錄聚合酵素鏈鎖反應（RT-PCR）的檢測
  • 聚集試驗
  • 固相分析
  • 流通分析
  • 其他測試類型
  • 全球病毒診斷檢測套組市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 研究辦公室
  • 診所
  • 醫院
  • 其他最終用戶
  • 全球病毒診斷檢測套組市場：按傳統檢測（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法（ELISA）
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 蛋白質印跡法
  • 病毒培養檢測
  • 全球病毒診斷檢測套組市場：依快速檢測類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 橫向流動化驗（LFA）
  • 免疫疾病層析試紙測試
  • 逆轉錄環介導等溫擴增（RT-LAMP）
  • 快速抗原檢測

第7章 區域和國家分析

  • 全球病毒診斷檢測套組市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球病毒診斷檢測套組市場：按國家、實際結果和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 病毒診斷檢測套組市場：競爭格局
  • 病毒診斷檢測套組市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Becton Dickinson and Company
  • Quest Diagnostics Incorporated
  • Grifols SA
  • Hologic Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Ortho Clinical Diagnostics
  • Myriad Genetics Inc.
  • Seegene Inc.
  • OraSure Technologies Inc.
  • Meridian Bioscience Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年病毒診斷檢測套組市場：提供新機會的國家
  • 2029年病毒診斷檢測套組市場：細分市場帶來新機會
  • 2029年病毒診斷檢測套組市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31494u

Viral diagnostic test kits are instruments used in medicine to detect viral infections in clinical samples from patients. These kits typically contain reagents, antibodies, or other substances that interact with specific viral antigens or genetic material, generating a measurable signal. They can detect viral particles, antigens, or genetic material (such as RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.

The main types of viral diagnostic test kits include traditional tests and rapid tests. Traditional viral diagnostic tests are established laboratory-based methods that involve culturing the virus, detecting viral antigens, or measuring antibody responses. Examples of these tests include direct fluorescent antibody (DFA) tests, immunochromatographic assays, reverse transcriptase polymerase chain reaction (rt-PCR) based tests, agglutination assays, solid phase assays, flow through assays, and others. These tests are used by various end-users including research laboratories, clinics, hospitals, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The viral diagnostic test kits market research report is one of a series of new reports from The Business Research Company that provides viral diagnostic test kits market statistics, including viral diagnostic test kits industry global market size, regional shares, competitors with viral diagnostic test kits market share, detailed viral diagnostic test kits market segments, market trends, and opportunities, and any further data you may need to thrive in the viral diagnostic test kits industry. This viral diagnostic test kits research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $16.26 billion in 2024 to $17.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing healthcare expenditure, increasing global travel, a rise in chronic viral infections, a rise in demand for home testing kits, and growth in personalized medicine.

The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $23.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing Ebola virus infections, increasing hemorrhagic fever, rising prevalence of viral infections, increasing prevalence of respiratory syncytial virus, and increasing prevalence of hepatitis. Major trends in the forecast period include technological advancements, point-of-care testing, AI and data analytics, integration with digital health records, and next-generation sequencing.

The forecast of 7.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for viral antigen reagents and lateral flow assay components, sourced from key regions such as China and South Korea, could lead to testing shortages during outbreaks and increased diagnostic expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of viral infections is anticipated to drive the growth of the viral diagnostic test kits market in the coming years. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can result in a wide range of symptoms, varying from mild to severe, affecting different parts of the body. This rise in infections is attributed to factors such as global travel, urbanization, climate change influencing vector-borne diseases, and the emergence of new viral strains capable of causing outbreaks or expanding into new regions. Viral diagnostic test kits play a crucial role in identifying and confirming specific viral infections by detecting viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood, saliva, or nasal swabs. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2022, there were 2,126 new cases of acute hepatitis B reported alongside 16,729 newly reported cases of chronic hepatitis B in the United States. Additionally, 14 jurisdictions in the US reported rates of acute hepatitis B higher than the national average, highlighting the need for effective diagnostic tools. Therefore, the increasing prevalence of viral infections is a key driver behind the growth of the viral diagnostic test kits market.

Leading companies in the viral diagnostic test kits market are focusing on developing innovative products, such as virus detection kits, to maintain their competitive edge. A virus detection kit is a diagnostic tool designed to detect specific viruses in biological samples, offering quick and accurate results to support effective disease monitoring and management. For example, in August 2024, BlueStain Global Ltd, a UK-based company, introduced the MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test that identifies the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to improve public health responses by enabling early detection and containment of mpox outbreaks, especially in resource-limited environments.

In June 2023, Avacta Life Sciences, a UK-based company in the life sciences sector, completed the acquisition of Coris Bioconcept for £7.4 million ($9.35 million). This strategic move by Avacta is aimed at bolstering its rapid diagnostic test portfolio, thereby strengthening its capabilities in healthcare diagnostics and expanding its market presence, particularly in the fields of infectious disease management and point-of-care testing. Coris Bioconcept, based in Belgium, specializes in the development and manufacturing of rapid diagnostic test kits, primarily focusing on lateral flow tests designed to detect viral and bacterial pathogens.

Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Myriad Genetics Inc., Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc, Biodesix Inc.

North America was the largest region in the viral diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viral diagnostic test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viral diagnostic test kits market consists of sales of viral culture kits, molecular diagnostic kits, antibody detection kits, antigen detection kits, and multiplex PCR kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Diagnostic Test Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viral diagnostic test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral diagnostic test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral diagnostic test kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test: Traditional Tests; Rapid Test
  • 2) By Test Type: Direct Fluorescent Antibody (DFA) Test; Immunochromatographic Assay; Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test; Agglutination Assay; Solid Phase Assay; Flow Through Assay; Other Test Types
  • 3) By End-User: Research Laboratories; Clinics; Hospitals; Other End Users
  • Subsegments:
  • 1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Polymerase Chain Reaction (PCR) Tests; Western Blot; Viral Culture Testing
  • 2) By Rapid Test: Lateral Flow Assays (LFA); Immunochromatographic Strip Tests; Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP); Rapid Antigen Tests
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Quest Diagnostics Incorporated; Grifols S.A.; Hologic Inc.; PerkinElmer Inc.; bioMerieux SA; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Ortho Clinical Diagnostics; Myriad Genetics Inc.; Seegene Inc.; OraSure Technologies Inc.; Meridian Bioscience Inc.; DiaSorin S.p.A.; Trinity Biotech plc; Biodesix Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Viral Diagnostic Test Kits Market Characteristics

3. Viral Diagnostic Test Kits Market Trends And Strategies

4. Viral Diagnostic Test Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Diagnostic Test Kits Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Viral Diagnostic Test Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Viral Diagnostic Test Kits Market Growth Rate Analysis
  • 5.4. Global Viral Diagnostic Test Kits Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Viral Diagnostic Test Kits Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Viral Diagnostic Test Kits Total Addressable Market (TAM)

6. Viral Diagnostic Test Kits Market Segmentation

  • 6.1. Global Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Tests
  • Rapid Test
  • 6.2. Global Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Fluorescent Antibody (DFA) Test
  • Immunochromatographic Assay
  • Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test
  • Agglutination Assay
  • Solid Phase Assay
  • Flow Through Assay
  • Other Test Types
  • 6.3. Global Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Laboratories
  • Clinics
  • Hospitals
  • Other End Users
  • 6.4. Global Viral Diagnostic Test Kits Market, Sub-Segmentation Of Traditional Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR) Tests
  • Western Blot
  • Viral Culture Testing
  • 6.5. Global Viral Diagnostic Test Kits Market, Sub-Segmentation Of Rapid Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lateral Flow Assays (LFA)
  • Immunochromatographic Strip Tests
  • Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP)
  • Rapid Antigen Tests

7. Viral Diagnostic Test Kits Market Regional And Country Analysis

  • 7.1. Global Viral Diagnostic Test Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Viral Diagnostic Test Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Diagnostic Test Kits Market

  • 8.1. Asia-Pacific Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Diagnostic Test Kits Market

  • 9.1. China Viral Diagnostic Test Kits Market Overview
  • 9.2. China Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Diagnostic Test Kits Market

  • 10.1. India Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Diagnostic Test Kits Market

  • 11.1. Japan Viral Diagnostic Test Kits Market Overview
  • 11.2. Japan Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Diagnostic Test Kits Market

  • 12.1. Australia Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Diagnostic Test Kits Market

  • 13.1. Indonesia Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Diagnostic Test Kits Market

  • 14.1. South Korea Viral Diagnostic Test Kits Market Overview
  • 14.2. South Korea Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Diagnostic Test Kits Market

  • 15.1. Western Europe Viral Diagnostic Test Kits Market Overview
  • 15.2. Western Europe Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Diagnostic Test Kits Market

  • 16.1. UK Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Diagnostic Test Kits Market

  • 17.1. Germany Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Diagnostic Test Kits Market

  • 18.1. France Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Diagnostic Test Kits Market

  • 19.1. Italy Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Diagnostic Test Kits Market

  • 20.1. Spain Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Diagnostic Test Kits Market

  • 21.1. Eastern Europe Viral Diagnostic Test Kits Market Overview
  • 21.2. Eastern Europe Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Diagnostic Test Kits Market

  • 22.1. Russia Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Diagnostic Test Kits Market

  • 23.1. North America Viral Diagnostic Test Kits Market Overview
  • 23.2. North America Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Diagnostic Test Kits Market

  • 24.1. USA Viral Diagnostic Test Kits Market Overview
  • 24.2. USA Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Diagnostic Test Kits Market

  • 25.1. Canada Viral Diagnostic Test Kits Market Overview
  • 25.2. Canada Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Diagnostic Test Kits Market

  • 26.1. South America Viral Diagnostic Test Kits Market Overview
  • 26.2. South America Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Diagnostic Test Kits Market

  • 27.1. Brazil Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Diagnostic Test Kits Market

  • 28.1. Middle East Viral Diagnostic Test Kits Market Overview
  • 28.2. Middle East Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Diagnostic Test Kits Market

  • 29.1. Africa Viral Diagnostic Test Kits Market Overview
  • 29.2. Africa Viral Diagnostic Test Kits Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Diagnostic Test Kits Market Competitive Landscape And Company Profiles

  • 30.1. Viral Diagnostic Test Kits Market Competitive Landscape
  • 30.2. Viral Diagnostic Test Kits Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Viral Diagnostic Test Kits Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Grifols S.A.
  • 31.4. Hologic Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. bioMerieux SA
  • 31.7. Quidel Corporation
  • 31.8. Sysmex Corporation
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. QIAGEN N.V.
  • 31.11. Ortho Clinical Diagnostics
  • 31.12. Myriad Genetics Inc.
  • 31.13. Seegene Inc.
  • 31.14. OraSure Technologies Inc.
  • 31.15. Meridian Bioscience Inc.

32. Global Viral Diagnostic Test Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Diagnostic Test Kits Market

34. Recent Developments In The Viral Diagnostic Test Kits Market

35. Viral Diagnostic Test Kits Market High Potential Countries, Segments and Strategies

  • 35.1 Viral Diagnostic Test Kits Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Viral Diagnostic Test Kits Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Viral Diagnostic Test Kits Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer